IN BRIEF: Herald Investment names Andrew Joy as chair designate

Mon, 20th Jun 2022 14:21

Herald Investment Trust PLC - London-based investment firm - Announces appointment of Biotech Growth Trust PLC Chair Andrew Joy as chair designate from October 1. Joy is set to replace current Chair Tom Black after firm's annual general meeting in April 2023. Black has served nearly ten years and "will work closely with Andrew to ensure an orderly transition," company says. Joy has been chair of Biotech Growth Trust, a London-based investor in global biotechnology companies, since July 2016, a role he will retire from next month.

Current stock price: 1,568.00 pence, up 0.3% on Monday

12-month change: down 28%

By Tom Budszus; tombudszus@alliancenews.com